Cambiar Investors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-59,866
| Closed | -$2.46M | – | 150 |
|
|
2022
Q1 | $2.46M | Buy |
59,866
+1,937
| +3% | +$79.5K | 0.09% | 113 |
|
|
2021
Q4 | $2.52M | Buy |
57,929
+18,296
| +46% | +$795K | 0.09% | 119 |
|
|
2021
Q3 | $1.98M | Sell |
39,633
-485
| -1% | -$24.3K | 0.07% | 134 |
|
|
2021
Q2 | $2.53M | Buy |
40,118
+8,343
| +26% | +$526K | 0.08% | 136 |
|
|
2021
Q1 | $2.95M | Buy |
31,775
+9,157
| +40% | +$851K | 0.1% | 109 |
|
|
2020
Q4 | $2.03M | Buy |
22,618
+4,331
| +24% | +$388K | 0.08% | 137 |
|
|
2020
Q3 | $1.89M | Sell |
18,287
-12,208
| -40% | -$1.26M | 0.09% | 131 |
|
|
2020
Q2 | $2.41M | Sell |
30,495
-2,138
| -7% | -$169K | 0.11% | 88 |
|
|
2020
Q1 | $1.89M | Sell |
32,633
-9,091
| -22% | -$526K | 0.09% | 97 |
|
|
2019
Q4 | $2.25M | Sell |
41,724
-2,123
| -5% | -$115K | 0.07% | 121 |
|
|
2019
Q3 | $2.29M | Sell |
43,847
-8,221
| -16% | -$430K | 0.07% | 119 |
|
|
2019
Q2 | $2.52M | Buy |
+52,068
| New | +$2.52M | 0.07% | 122 |
|